Macrogenics MGNX
NASDAQ MGNX
$3.83 +0.06 (+1.46%)
As of: Sep 30, 2026 · 10:25 AM EDT

Macrogenics (MGNX) EV to EBITDA (2013 - 2015)

Updated

Macrogenics' (MGNX) EV to EBITDA was 298.74 for Q2 2015, up 422.6% from the prior quarter.

Analysis

Macrogenics (MGNX) EV to EBITDA (2013 - 2015) Analysis & Trends

Over the twelve months ended Jun 30, 2015, Macrogenics' EV to EBITDA came in at 101.53; for FY2013, it was 45.56.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Macrogenics 258.40 Mn -59.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 298.74
Mar 31, 2015 57.17
Mar 31, 2014 292.50
Dec 31, 2013 45.52
API Access

Macrogenics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MGNX&period=max&api_key=YOUR_API_KEY